Detalhe da pesquisa
1.
Differentially expressed messenger RNA/proteins can distinguish teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection tissue.
Cancer
; 129(4): 634-642, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36504384
2.
Transcriptome analysis reveals upregulation of immune response pathways at the invasive tumour front of metastatic seminoma germ cell tumours.
Br J Cancer
; 126(6): 937-947, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35022523
3.
Prevalence and potential biological role of TERT amplifications in ALK translocated adenocarcinoma of the lung.
Histopathology
; 78(4): 578-585, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32946634
4.
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma.
Cancer Immunol Immunother
; 69(4): 523-533, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31960110
5.
Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors.
BMC Cancer
; 20(1): 408, 2020 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32397977
6.
Immune-phenotyping of pleomorphic dermal sarcomas suggests this entity as a potential candidate for immunotherapy.
Cancer Immunol Immunother
; 68(6): 973-982, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963193
7.
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.
J Thorac Oncol
; 19(1): 160-165, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429463
8.
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC.
J Thorac Oncol
; 18(11): 1550-1567, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37473958
9.
Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue.
Virchows Arch
; 482(4): 697-706, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36367572
10.
Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors.
Eur J Cancer
; 179: 124-135, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521334
11.
Biomarkers for Homologous Recombination Deficiency in Cancer.
J Pers Med
; 11(7)2021 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34203281
12.
Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy.
NPJ Precis Oncol
; 5(1): 52, 2021 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135436
13.
Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation.
BMC Med Genomics
; 14(1): 62, 2021 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33639937
14.
Expression Profiling of Extracellular Matrix Genes Reveals Global and Entity-Specific Characteristics in Adenoid Cystic, Mucoepidermoid and Salivary Duct Carcinomas.
Cancers (Basel)
; 12(9)2020 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32878206
15.
Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe.
J Clin Pathol
; 2020 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32737190
16.
Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology.
J Thorac Dis
; 11(Suppl 1): S3-S8, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30775023
17.
Comparison of in situ and extraction-based methods for the detection of MET amplifications in solid tumors.
Comput Struct Biotechnol J
; 17: 1339-1347, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31762957
18.
First report on two cases of pleomorphic dermal sarcoma successfully treated with immune checkpoint inhibitors.
Oncoimmunology
; 8(12): e1665977, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31741767
19.
The value of tumor mutational burden to select patients for immunotherapy.
Expert Rev Anticancer Ther
; 21(1): 1-3, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33043725
20.
Targeted RNA-sequencing for the evaluation of gene fusions in lung tumors: current status and future prospects.
Expert Rev Mol Diagn
; 21(6): 531-534, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33887162